What it is
CJC-1295 is an investigational analogue designed to influence growth-hormone-releasing hormone signalling. Online products may use the name for different formulations, including versions described as containing a drug-affinity complex.
What the evidence can tell us
Early human studies examined pharmacology and hormone responses in small groups. Those findings do not establish broad anti-aging, muscle-building, fat-loss, recovery, or wellness benefits, and they do not validate products sold by unrelated vendors.
Canadian context
Health Canada’s 2026 advisory names CJC-1295 among unauthorized injectable peptide drugs. No authorized CJC-1295 drug product was identified in the Drug Product Database on the date checked.
Key unknowns
Long-term clinical benefit and safety are not established. Products sold outside an authorized supply chain also present uncertainty about identity, concentration, formulation, sterility, and contaminants.
Source trail